Researching a product can help someone take part in a medical decision. It does not establish that the product is appropriate for their health history or that the claimed benefit is supported.
A prescribing clinician needs to evaluate the specific substance, intended use, alternatives, and risks. “Peptide” is a description of a type of molecule, not a single treatment with one evidence base.
Start with the problem to be addressed
A request such as improving recovery, energy, or sleep can contain several different concerns. Describing what has changed makes it possible to investigate the problem before choosing a product.
Self-tracked data can contribute, but lab results are interpreted with symptoms, history, and other findings.[1] A measurement outside a preferred online range does not automatically create a reason for a prescription.
Ask whether the evidence matches the proposal
A study needs to apply to the substance, formulation, route, and intended outcome being discussed. A biological mechanism alone does not establish a meaningful benefit for an individual.
The same applies to product status. Compounded medications are not FDA-approved, and FDA does not review their safety, effectiveness, or quality before marketing. They are also different from FDA-approved generics.[2]
Shared decisions can include another direction
The assessment may point toward further investigation, a different option, or no medication. A clear explanation should describe why and what information would affect that decision.
For a compounded preparation, FDA says the medical need must not be met by an approved drug.[2] The prescriber should explain the relevant need, and the dispensing pharmacy should be identifiable.
